Higher and lower active circulating VWF levels: different facets of von Willebrand disease-Reference-Cited by-同舟云学术

Higher and lower active circulating VWF levels: different facets of von Willebrand disease

Published:2015-10-12 Issue:5 Volume:171 Page:845-853
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Casonato Alessandra¹,Pontara Elena²,Morpurgo Margherita³,Sartorello Francesca¹,De Groot Philip G.⁴,Cattini Maria G.²,Daidone Viviana²,De Marco Luigi⁵⁶

Affiliation:

1. Department of Medicine; University of Padua Medical School; Padua Italy

2. Department of Cardiologic, Thoracic and Vascular Sciences; University of Padua; Padua Italy

3. Pharmaceutical Chemistry and Pharmacology Department; University of Padua; Padua Italy

4. Department of Clinical Chemistry and Haematology; University Medical Centre Utrecht; Utrecht the Netherlands

5. Department of Translational Research; Stem Cells Unit; IRCCS; C.R.O.; Aviano Italy

6. Department of Molecular Medicine; The Scripps Research Institute; La Jolla CA USA

Funder

Ministero dell'Universita’ e della Ricerca Scientifica e Tecnologica

Italian Ministry of Public Health

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13785/fullpdf

Reference30 articles.

1. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction and the presence of all von Willebrand factor multimers in plasma;Casonato;Blood,1989

2. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia;Casonato;Thrombosis and Haemostasis,1990

3. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation;Casonato;Thrombosis and Haemostasis,1999

4. Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?;Casonato;British Journal of Haematology,2001

5. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis;Casonato;Thrombosis and Haemostasis,2007a

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor;PLOS ONE;2019-02-13

2. Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease;Microcirculation;2018-11-19

3. Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue;PLOS ONE;2017-06-22

4. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis;Thrombosis and Haemostasis;2016